Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Five regions in the U.S. have been selected to implement a new preventive health initiative to improve care for people with a cluster of chronic conditions known as cardiovascular-kidney-metabolic ...

A new study from Karolinska Institutet explores the connection between inflammatory bowel disease (IBD) and chronic kidney ...

Living kidney donors with discordant kidney function measures had lower eGFR after donation and a higher risk for eGFR counts ...

Robert F. Kennedy Jr., laying out his early health agenda, said he would examine childhood vaccines, psychiatric drugs and other “formerly taboo” topics in investigating the causes of chronic disease.

Researchers at the University of Gothenburg have uncovered a critical mechanism that may pave the way for innovative ...

Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, ...

Cauliflower brings the crunch, paired with plenty of vitamins C, B6, B9 and K, along with fiber. It also contains compounds your body can use to neutralize certain toxins, a big help when your kidneys ...